Furosemide and spironolactone doses and hyponatremia in patients with heart failure
Abstract Background Hyponatremia, a marker of disease severity and prognosis, has been associated with various clinical factors and drug use, especially diuretics. Methods This observational prospective cohort study enrolled patients hospitalized at the University Hospital Center Split because of he...
Saved in:
Main Authors: | Ivan Velat (Author), Željko Bušić (Author), Marina Jurić Paić (Author), Viktor Čulić (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2020-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluation of Spironolactone in Combination with Furosemide in Cirrhotic Patients with Permagna (Large) Ascites
by: Tuty Mulyani, et al.
Published: (2017) -
Smart Spectrophotometric Methods for Concurrent Determination of Furosemide and Spironolactone Mixture in Their Pharmaceutical Dosage Forms
by: Hayam M. Lotfy, et al.
Published: (2022) -
CLINICAL AND PROGNOSTIC VALUE OF HYPONATREMIA IN PATIENTS WITH CHRONIC HEART FAILURE
by: N. T. Vatutin, et al.
Published: (2018) -
Association between dosing of spironolactone and outcomes in heart failure with preserved ejection fraction patients combined with chronic kidney disease------Balance of efficacy and risk
by: Jun-Feng Li, et al.
Published: (2023) -
PROGNOSTIC IMPACT OF COMMUNITY-ACQUIRED AND HOSPITAL-ACQUIRED HYPONATREMIA IN PATIENTS WITH DECOMPENSATED HEART FAILURE
by: D. Yu. Shchekochikhin, et al.
Published: (2015)